WALTHAM, MA—(Marketwired – January 11, 2018) – EarlySense, the market leader in contact–free continuous monitoring solutions across the care continuum, announced today that its under–the–mattress fertility tracker, Percept, has won the 2018 Baby Tech Audience Favorite award.
The Best of Baby Tech Awards recognizes and highlights outstanding achievement in fertility, pregnancy and baby technology products from around the world. Winners are selected based on a competitive selection process and a combination of esteemed judges, including a group of experts from the Good Housekeeping Institute, and online voting.
“We are proud that Percept received the Audience Favorite award, further establishing EarlySense as a leader of contact–free health tracking solutions,” said Avner Halperin, Co–Founder and CEO of EarlySense. “Providing women with accurate fertility prediction windows is crucial in helping couples plan ahead and conceive faster, and we are proud to offer this important product to the market.”
Percept is the world's first contact–free fertility tracker. Leveraging EarlySense's hospital–proven technology, Percept simply slides under the mattress, and quietly captures and translates a woman's heart and breathing rates into highly accurate fertility prediction data, providing her with a 6–day fertility window so she can get pregnant faster. In a clinical study, Percept was proven to be 31% more accurate than standard estimation methods.
Percept is registered with the U.S. Food and Drug Administration (FDA) as a medical device to accurately track women's fertility. Percept retails for $199 and is available for purchase on www.earlysense.com/percept and Amazon.
EarlySenseÂ® provides contact–free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense's FDA–cleared systems utilize Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes.
Used worldwide in hospitals, rehab and skilled nursing facilities, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls and pressure ulcers.
EarlySense offers clinically–proven technology to consumers with EarlySenseÂ® Liveâ¢ and Perceptâ¢. EarlySenseÂ® Liveâ¢ is the first at–home consumer health monitor powered by EarlySense's medically–proven sensor and AI analytics. Live is particularly useful for tracking the health and sleep of the aging population and children, to help facilitate better health choices. EarlySenseÂ® Perceptâ¢ is the first clinically–proven monitor for fertility and period tracking. It accurately tracks internal body signals and assists couples who are trying to conceive.
EarlySense has partnered with leading global technology companies including Samsung, Welch Allyn, iFit and Beurer. The company is based in Ramat Gan, Israel and Waltham, MA.